Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial

Background Cytoreductive surgery (CRS) and administration of hyperthermic intraperitoneal chemotherapy (HIPEC) have shown their efficacy in multiple malignancies and also could offer a prognostic benefit for patients with advanced ovarian cancer. Methods A prospective, single-center, parallel-group,...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgical oncology 2022-04, Vol.29 (4), p.2617-2625
Main Authors: Antonio, Cascales Campos Pedro, Alida, González Gil, Elena, Gil Gómez, Rocío, González Sánchez, Jerónimo, Martínez García, Luis, Alonso Romero José, Aníbal, Nieto Díaz, Francisco, Barceló Valcárcel, Jesús, Gómez Ruiz Álvaro, Pablo, Ramírez Romero, José, Gil Martínez
Format: Article
Language:English
Subjects:
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Chemotherapy
Cisplatin
Clinical trials
Combined Modality Therapy
Cytoreduction Surgical Procedures - adverse effects
Humans
Hyperthermia, Induced
Hyperthermic Intraperitoneal Chemotherapy
Medicine
Medicine & Public Health
Morbidity
Mortality
Neoadjuvant Therapy
Oncology
Ovarian cancer
Ovarian Neoplasms - pathology
Patients
Peritoneal Neoplasms - therapy
Peritoneal Surface Malignancy
Prospective Studies
Quality of Life
Surgery
Surgical Oncology
Survival
Survival Rate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!